Kuros Biosciences has appointed Dr. Philippe Saudan as chief development officer and member of the executive board with immediate effect. With a PhD in biology from the University of Lausanne, Switzerland, and a 16 year-career in the pharmaceutical industry, Saudan has held management roles in R&D and last served as Chief Scientific Officer of Cytos Biotechnology. Since February 2016, he has been working as Head of Integration at Kuros.
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK, and Switzerland
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
The versatile material polymethyl methacrylate (PMMA) is particularly impressive due to its durability and outstanding recyclability.
